Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today ...
The poster presentations include a post-hoc analysis reviewing the sustainability of the response of linaclotide in patients with chronic idiopathic constipation (CIC), as well as post-hoc analyses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results